OncoMatch/Clinical Trials/NCT06562166
Online Adaptive Radiotherapy for Cervical Cancer
Is NCT06562166 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2 trial studies non-drug interventions for cervical cancer.
This study aims to evaluate the clinical efficacy and safety of online adaptive radiotherapy for cervical cancer patients received radical radiotherapy. By comparing with image-guided radiotherapy, the study explores the potential advantages of online adaptive radiotherapy in reducing treatment toxicity and improving local control.
Check if I qualifyExtracted eligibility criteria
Cancer type
Cervical Cancer
Disease stage
Required: Stage II, IIIB, IIIC1
Performance status
ECOG 0–2(Ambulatory, capable of self-care)
Demographics
Prior therapy
Cannot have received: radiotherapy
Have received radiotherapy in the past
Cannot have received: chemotherapy
Have received chemotherapy in the past
Cannot have received: surgery
Have undergone radical surgery for cervical cancer
Lab requirements
Blood counts
NEUT ≥ 1.5*10^9/L, HGB ≥ 60g/L, platelets ≥ 100×10^9/L
Kidney function
blood creatinine <1.5 mg/dL
Liver function
AST and ALT are within 2 times the upper limit of normal
Complete blood count and basal metabolic indexes within 14 days before enrolment must meet the following requirements: NEUT ≥ 1.5*109/L, HGB ≥ 60g/L, platelets ≥ 100×109/, blood creatinine <1.5 mg/dL. AST and ALT are within 2 times the upper limit of normal
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT06562166 currently recruiting?
Yes, this trial is currently recruiting patients.
Can patients have received prior systemic therapy?
No. This trial requires treatment-naive patients — prior systemic therapy is an exclusion criterion.
What disease stage is eligible?
Stage II or IIIB or IIIC1 is required.
Is there an age limit?
Yes. Patients must be 80 years or younger.
Is this trial open to male patients?
No. This trial enrolls female patients only.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages